Cytokinetics (CYTK) Gross Profit Growth (1y) (2026)

Cytokinetics (CYTK) Gross Profit Growth (1y) (2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Profit Growth (1y) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 11.24%
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 15.59%
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 68.41%
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 33.01%
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -41.93%
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 57.16%
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 351.57%
10 Cytokinetics 10.31 Bn 9.14 Bn 25.89 Mn -61.22%

Historic Data

Download Data
DateValue
Jun 30, 2026 -61.22%
Mar 31, 2026 1,115.64%